Clarivate(US:CLVT) Prnewswire·2024-07-18 07:00Core Insights - BioWorld, published by Clarivate Plc, has won nine 2024 APEX Awards for Publication Excellence, highlighting its commitment to journalistic excellence and data-driven analysis [1][2][3] Awards and Recognition - The APEX Awards, now in their 36th year, recognize outstanding work in professional communications, with over 1,100 entries this year, making BioWorld's nine wins particularly significant [2] - BioWorld has been recognized in various categories, including Grand Award in Writing and Awards for Publication Excellence in multiple writing categories [11][18] Notable Publications - A Grand Award was given for the writing category to Nuala Moran for an article on advancements in spinal cord injury treatments, showcasing BioWorld's focus on impactful medical innovations [4] - An award for writing the entire issue was given to a team for a June 2023 issue that included significant industry news, such as a series A financing for a gene therapy company and phase III data from a major oncology conference [5] - A series on radiopharmaceuticals was recognized for exploring new treatment modalities in oncology, indicating BioWorld's depth in covering emerging medical technologies [6] Industry Trends - The biopharma sector has seen a notable increase in deal values, with a nearly 6% uptick in overall deal value and an 80% increase in M&A values compared to the previous year, reflecting a transformative shift in the industry landscape [18] - The Asia-Pacific biotech ecosystems are experiencing a resurgence post-COVID-19, with countries like Singapore, China, and Japan attracting international collaborations to enhance their biotech capabilities [19]